Company Filing History:
Years Active: 2013-2015
Title: Frederic Dargelas: Innovator in Pharmaceutical Formulations
Introduction
Frederic Dargelas is a notable inventor based in Pessac, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms that address misuse and enhance drug delivery.
Latest Patents
Dargelas holds three patents, with his latest innovations focusing on prolonged-release multimicroparticulate oral pharmaceutical forms. One of his patents describes a modified-release multimicroparticulate pharmaceutical form capable of maintaining the modified release of the active principle in an alcoholic solution while resisting attempts at misuse. Another patent outlines an oral solid dosage form containing analgesic properties, designed to prevent misuse through liquid extraction of the active principles using commonly available solvents. This innovative dosage form includes at least one salt of an analgesic active principle and an anti-misuse system that employs a quenching agent to induce complexation of the analgesic active principle salt when improperly extracted.
Career Highlights
Frederic Dargelas is currently associated with Flamel Technologies, where he continues to advance his research and development efforts in pharmaceutical formulations. His work is pivotal in creating safer medication options that mitigate the risks of misuse.
Collaborations
Dargelas collaborates with esteemed colleagues such as Florence Guimberteau and Gérard Soula, contributing to a dynamic research environment that fosters innovation in the pharmaceutical industry.
Conclusion
Frederic Dargelas exemplifies the spirit of innovation in the pharmaceutical sector through his groundbreaking patents and collaborative efforts. His work not only enhances drug delivery systems but also addresses critical issues related to medication misuse.